The salary of Rip Tianjin Toray is still good, with the salary of RMB 20-30K accounting for up to 33.3%, which will decrease by 4% in 2022 compared with 2021. The salary for a master's degree is ￥20.7K, and the salary for a doctoral degree is ￥23.6K.
Rip (Tianjin) Biopharmaceutical Co., Ltd. is a wholly-owned subsidiary of Rip Bio Group (stock code: 300119) The subsidiary has a registered capital of 84 million yuan and an annual operating income of over 300 million yuan. It is a large-scale and intensive manufacturing base integrating the research and development, production and marketing of animal pharmaceutical preparations in North China.
